Literature DB >> 9707307

Detection of bacteraemia in patients with fever and neutropenia using 16S rRNA gene amplification by polymerase chain reaction.

B E Ley1, C J Linton, D M Bennett, H Jalal, A B Foot, M R Millar.   

Abstract

Episodes of fever and neutropenia are common complications of treatment for cancer. The use of prophylactic and early empirical antibiotics has reduced mortality but decreases the sensitivity of diagnostic tests based on culture. The aim of this study was to determine the potential of a broad diagnostic approach (eubacterial) based on 16S rRNA gene amplification and sequencing to augment cultural methods of diagnosis of bacteraemia in patients with fever and neutropenia in a regional paediatric oncology centre. One hundred eleven patient-episodes of fever and neutropenia were evaluated during the study period, 17 of which were associated with positive blood cultures, as follows: Staphylococcus epidermidis (n = 6 episodes), Enterococcus faecium (n = 2), Streptococcus sanguis (n = 3), Streptococcus mitis (n = 3), Staphylococcus aureus (n = 1), Micrococcus spp. (n = 1), and Stenotrophomonas maltophilia (n = 1). Eubacterial polymerase chain reaction (PCR) detected bacterial DNA in nine of 11 blood culture-positive episodes for which a sample was available for PCR; the species identified by sequence analysis were identical to those derived from the conventional identification of the cultured isolates. Bacterial DNA was detected in 20 episodes (21 bacterial sequences) associated with negative blood cultures, 18 of which occurred in patients who were receiving antibiotics at the time of sample collection. The species presumptively identified by partial 16S rRNA gene sequencing were as follows: Pseudomonas spp. (n = 6 episodes), Acinetobacter spp. (n =5 ); Escherichia spp. (n = 3); Moraxella spp. (n = 3); Staphylococcus spp. (n = 2); Neisseria spp. (n = 1); and Bacillus spp. (n = 1). The results of this study suggest that molecular techniques can augment cultural methods in the diagnosis of bacteraemia in patients who have been treated with antibiotics.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9707307     DOI: 10.1007/bf01699981

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  34 in total

1.  The estimation of the bactericidal power of the blood.

Authors:  A A Miles; S S Misra; J O Irwin
Journal:  J Hyg (Lond)       Date:  1938-11

2.  BacT/Alert: an automated colorimetric microbial detection system.

Authors:  T C Thorpe; M L Wilson; J E Turner; J L DiGuiseppi; M Willert; S Mirrett; L B Reller
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

3.  Changes in the spectrum of organisms causing bacteremia and fungemia in immunocompromised patients due to venous access devices.

Authors:  T E Kiehn; D Armstrong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

Review 4.  The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies.

Authors:  P A Pizzo; M Rubin; A Freifeld; T J Walsh
Journal:  J Pediatr       Date:  1991-11       Impact factor: 4.406

5.  Sensitive and universal method for microbial DNA extraction from blood products.

Authors:  N Golbang; J P Burnie; P E Klapper; A Bostock; P Williamson
Journal:  J Clin Pathol       Date:  1996-10       Impact factor: 3.411

6.  Bacteremia due to glucose non-fermenting gram-negative bacilli in patients with hematological neoplasias and solid tumors.

Authors:  R Martino; C Martínez; R Pericas; R Salazar; C Solá; S Brunet; A Sureda; A Domingo-Albós
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

7.  Laboratory experience and guidelines for avoiding false positive polymerase chain reaction results.

Authors:  T Victor; A Jordaan; R du Toit; P D Van Helden
Journal:  Eur J Clin Chem Clin Biochem       Date:  1993-08

Review 8.  Blood cultures and immunocompromised patients.

Authors:  C W Stratton
Journal:  Clin Lab Med       Date:  1994-03       Impact factor: 1.935

Review 9.  Nonhemolytic, noninfectious transfusion reactions.

Authors:  J C Barton
Journal:  Semin Hematol       Date:  1981-04       Impact factor: 3.851

10.  Clinical and epidemiological features of an outbreak of acinetobacter infection in an intensive therapy unit.

Authors:  M Crowe; K J Towner; H Humphreys
Journal:  J Med Microbiol       Date:  1995-07       Impact factor: 2.472

View more
  29 in total

1.  Does blood of healthy subjects contain bacterial ribosomal DNA?

Authors:  S Nikkari; I J McLaughlin; W Bi; D E Dodge; D A Relman
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Nonculture prediction of Neisseria meningitidis susceptibility to penicillin.

Authors:  A Antignac; J M Alonso; M K Taha
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

Review 3.  The role of DNA amplification technology in the diagnosis of infectious diseases.

Authors:  M Louie; L Louie; A E Simor
Journal:  CMAJ       Date:  2000-08-08       Impact factor: 8.262

4.  DNase pretreatment of master mix reagents improves the validity of universal 16S rRNA gene PCR results.

Authors:  Alexandra Heininger; Marlies Binder; Andreas Ellinger; Konrad Botzenhart; Klaus Unertl; Gerd Döring
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

5.  Rapid identification of bacteria from positive blood cultures by fluorescence-based PCR-single-strand conformation polymorphism analysis of the 16S rRNA gene.

Authors:  C Y Turenne; E Witwicki; D J Hoban; J A Karlowsky; A M Kabani
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

6.  Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis.

Authors:  M K Taha
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

7.  Use of quantitative 16S ribosomal DNA detection for diagnosis of central vascular catheter-associated bacterial infection.

Authors:  S Warwick; M Wilks; E Hennessy; J Powell-Tuck; M Small; J Sharp; M R Millar
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

8.  Real-time quantitative broad-range PCR assay for detection of the 16S rRNA gene followed by sequencing for species identification.

Authors:  Franziska Zucol; Roland A Ammann; Christoph Berger; Christoph Aebi; Martin Altwegg; Felix K Niggli; David Nadal
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

9.  Frequent occurrence of fever in patients who have undergone endoscopic submucosal dissection for colorectal tumor, but bacteremia is not a significant cause.

Authors:  Kentaro Izumi; Taro Osada; Naoto Sakamoto; Tomohiro Kodani; Yoshie Higashihara; Hideaki Ritsuno; Tomoyoshi Shibuya; Akihito Nagahara; Tatsuo Ogihara; Ken Kikuchi; Sumio Watanabe
Journal:  Surg Endosc       Date:  2014-05-23       Impact factor: 4.584

10.  Broad-range bacterial detection and the analysis of unexplained death and critical illness.

Authors:  Simo Nikkari; Fred A Lopez; Paul W Lepp; Paul R Cieslak; Stephen Ladd-Wilson; Douglas Passaro; Richard Danila; David A Relman
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.